ea0090ep433 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023
Ugur Kader
, Ozbay Umur
, Mızrak Mithat
, Aydın Suleyman
Introduction: Pancreatitis is one of the serious side effects of glucagon-like peptide-1 receptor analog exenatide, which is an incretin hormone with anti-glycemic effects secreted from the intestine and is used for treating type 2 diabetes.Case: A 60-year-old female patient with type 2 diabetes mellitus for 11 years had been using exenatide for 6 years (no history of acute pancreatitis) along with insulin glargine and metformin. She was admitted to the ...